Ala. Top Court Reverses Class Cert. In Duract Case

Law360, New York (January 19, 2010, 1:44 PM EST) -- Alabama's high court has vacated the certification of a class of health insurers in a suit accusing Wyeth of unjustly enriching itself in connection with Duract, an anti-inflammatory drug that was taken off the market in the late 1990s because of its association with liver problems.

The Alabama Supreme Court issued its decision Friday, thwarting attempts by Blue Cross and Blue Shield of Alabama, which brought the suit, to certify a nationwide class of health insurers.

The Supreme Court held that class certification would be inappropriate...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.